Carol Schafer
Direttore/Membro del Consiglio presso REPARE THERAPEUTICS INC.
Patrimonio netto: 3 M $ in data 31/05/2024
Profilo
Carol Anne Schafer's current jobs include being an Independent Director at Insmed, Inc., Immunome, Inc., Kura Oncology, Inc., Repare Therapeutics, Inc., and Director at Onegoal New York.
She is also the Managing Partner at Hyphen Advisors LLC.
Her former jobs include being the Vice Chairman-Equity Capital Markets at Wells Fargo Securities LLC, Independent Director at Idera Pharmaceuticals, Inc., Five Prime Therapeutics, Inc., VP-Finance, Business Development & Communications at Lexicon Pharmaceuticals, Inc., and MD, VP & Head-Equity Capital Markets at J.P.
Morgan & Co., Inc. (Old).
She completed her undergraduate degree at Boston College and holds an MBA from The Leonard N Stern School of Business.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
INSMED INCORPORATED
0.04% | 13/05/2024 | 58 259 ( 0.04% ) | 3 M $ | 31/05/2024 |
REPARE THERAPEUTICS INC.
0.02% | 15/04/2024 | 8 000 ( 0.02% ) | 27 840 $ | 31/05/2024 |
IMMUNOME, INC.
-.--% | 01/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
KURA ONCOLOGY, INC.
-.--% | 05/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Carol Schafer
Società | Posizione | Inizio |
---|---|---|
REPARE THERAPEUTICS INC. | Direttore/Membro del Consiglio | 01/03/2019 |
INSMED INCORPORATED | Direttore/Membro del Consiglio | 01/04/2020 |
KURA ONCOLOGY, INC. | Direttore/Membro del Consiglio | 03/06/2021 |
IMMUNOME, INC. | Direttore/Membro del Consiglio | 02/01/2024 |
Hyphen Advisors LLC | Amministratore Delegato | 01/01/2018 |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York. | Direttore/Membro del Consiglio | 01/03/2019 |
Precedenti posizioni note di Carol Schafer
Società | Posizione | Fine |
---|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Direttore/Membro del Consiglio | 28/09/2022 |
FIVE PRIME THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 16/04/2021 |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment ManagersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Corporate Officer/Principal | 01/09/2018 |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Carol Schafer
Boston College | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
LEXICON PHARMACEUTICALS, INC. | Health Technology |
INSMED INCORPORATED | Health Technology |
IMMUNOME, INC. | Health Technology |
KURA ONCOLOGY, INC. | Health Technology |
REPARE THERAPEUTICS INC. | Health Technology |
Aziende private | 6 |
---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Five Prime Therapeutics, Inc.
Five Prime Therapeutics, Inc. BiotechnologyHealth Technology Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of novel protein therapeutics. Its product candidates includes, Cabiralizumab (FPA008), Bemarituzumab (FPA144), and FPA150. The FPA008 is an antibody that inhibits colony stimulating factor-1, or CSF1, receptor, or CSF1R, that are developing in rheumatoid arthritis and plan to clinically develop in pigmented villonodular synovitis, or PVNS, and in combination with nivolumab in multiple cancers. The FPA144 is an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b, that are developing to treat patients with gastric cancer. The FPA150 is a CD8 T cell checkpoint which targets B7-H4 that is developing as a monotherapy in multiple cancers. The company was founded by Lewis T. Williams in December 2001 and is headquartered in South San Francisco, C. | Health Technology |
J.P. Morgan & Co., Inc. (Old) | Finance |
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment ManagersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients. | Finance |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York. | Commercial Services |
Hyphen Advisors LLC |
- Borsa valori
- Insiders
- Carol Schafer